For cancer patients, the timing of vaccination is crucial. It is generally recommended that patients receive PCV13 before starting immunosuppressive cancer treatments if possible. This is to ensure the body can mount an adequate immune response. However, the specific timing and need for vaccination should be determined by the healthcare provider based on the patient's individual circumstances and treatment plan.
